Speakers

Chris Mason

Founder & Chief Scientific Officer

Avrobio

David Cooper

Vice President, Clinical Development, CNS

uniQure

Elena Hernandez Martinez de Lapiscina

Scientific Officer & Clinical Neurologist

European Medicines Agency

Federico Mingozzi

Chief Scientific Officer

Spark Therapeutics

Gavin Corcoran

Chief R&D Officer

Sio Gene Therapies

Grace Liang

Vice President, Clinical Development

Neurocrine Biosciences

Jan Vesper

Professor of Neurosurgery

Heinrich-Heine- University

Jay Barth

Chief Medical Officer

Lexeo Therapeutics

Krystof Bankiewicz

Professor, Neurosurgery

The Ohio State University

Lucie Bruijn

Senior Director, Translational Medicine

Novartis Gene Therapies

Manuela Corti

Assistant Professor

University of Florida

Maria Lopez-Bresnahan

Senior Vice President & Head of Translational Medicine & Clinical Development

Voyager Therapeutics

Martin Citron

Vice President, Neuroscience

UCB

Michael Linden

Chief Scientific Officer

Handl Therapeutics

Nathalie Cartier

CNS

AskBio

Olga Uspenskaya- Cadoz

Vice President, Clinical Development

Prevail Therapeutics

Olivier Danos

Chief Scientific Officer

REGENXBIO

Patrick Ginty

Head of Gene Therapy Regulatory Affairs

Handl Therapeutics

Ralph Laufer

Chief Scientific Officer

Lysogene

Richard Porter

Chief Executive Officer

Corlieve Therapeutics

Samir Koirala

Director of Research Genetic & Neurodevelopmental Disorders

Biogen

Stephane Palfi

Professor & Head of Neurosurgery

Henri Mondor Medical Center, Paris University (UPEC)

Suyash Prasad

Chief Medical Officer & Head of Research & Development

Taysha Gene Therapies

William Gray

Professor of Neurosurgery

Cardiff University